The price, and that is confidential and was negotiated for a maximum of 300 huge number of doses, is a little lower than the $19.50 a photo the United States agreed to purchase a first shipment of hundred million doses of the identical vaccine, in series with what Reuters reported in November.
The EU file dated Nov. eighteen was circulated internally following the EU announced its supply deal with Pfizer and the German partner BioNTech of its on Nov. eleven.
The EU drug regulator is actually likely to decide on Monday on approval for the Pfizer vaccine following the photo was authorised in a few countries, including Britain and the United States.
On Thursday Belgian declare secretary with the budget Eva De Bleeker printed on Twitter a table with prices Belgium will shell out pharmaceutical companies for their COVID 19 vaccines. She retracted the article shortly after posting.
In that dining room table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) per dose, top many to believe that has been the entire cost agreed by the EU.
Various other vaccines in the family table were furthermore shown with prices lower than rates disclosed by EU sources.
“There is , naturally, a total fee along with a cost upon delivery,” an EU official involved in talks with vaccine makers told Reuters when asked to clarify the difference between the EU and Belgian prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament last week. In that public hearing, De Beeker stated Belgium’s budgeted price tags were still partial.
Underneath EU prior purchase deals for COVID-19 vaccines, the bloc believes upfront payments with business enterprises to secure doses before they’re approved. After approvals, EU governments can pay the rest to get reserved doses.
The EU hasn’t revealed the initial transaction agreed with Pfizer.
Nevertheless, it said in October that it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with an additional 1.45 billion euros budgeted for initial payments to Pfizer-BioNTech, Moderna and Curevac.
It has since agreed supply deals with all six corporations and it is negotiating a seventh agreement with Novavax.